SAXA Equity Partners, LLC (“SAXA”) began as a private equity firm specializing in the acquisition and development of early-stage (pre-clinical) life science assets. As an outgrowth of that experience—in particular, sourcing the pipeline of potential portfolio assets—the company subsequently developed the SAXA Intellectual Property Exchange, or SIPEx. SIPEx is a global online interactive marketplace servicing the needs of licensors and licensees of intellectual property, initially focusing on life science assets and eventually expanding to other types of intellectual property. SAXA can play a significant role in the evolution of the traditional market for such assets, not only by making the transactional process (including contract negotiation and drafting) much easier, but also by facilitating relationships between licensors and licensees via a comprehensive and secure online marketplace. SAXA invites any interested licensors or licensees to contact the company through its web page at www.saxaequity.com.